CTX-M-type β-lactamases: A successful story of antibiotic resistance

Marco Maria D'Andrea, Fabio Arena, Lucia Pallecchi, Gian Maria Rossolini

Research output: Contribution to journalArticle

Abstract

Production of extended-spectrum β-lactamases (ESBLs) is the principal mechanism of resistance to oxyimino-cephalosporins evolved by members of the family Enterobacteriaceae. Among the several ESBLs emerged among clinical pathogens, the CTX-M-type enzymes have proved the most successful in terms of promiscuity and diffusion in different epidemiological settings, where they have largely replaced and outnumbered other types of ESBLs. Originated by the capture and mobilization of chromosomal β-lactamase genes of strains of Kluyvera species, the blaCTX-M genes have become associated with a variety of mobile genetic elements that have mediated rapid and efficient inter-replicon and cell-to-cell dissemination involving highly successful enterobacterial lineages (e.g. Escherichia coli ST131 and ST405, or Klebsiella pneumoniae CC11 and ST147) to yield high-risk multiresistant clones that have spread on a global scale. The CTX-Mβ-lactamase lineage exhibits a striking plasticity, with a large number of allelic variants belonging in several sublineages, which can be associated with functional heterogeneity of clinical relevance. This review article provides an update on CTX-M-type ESBLs, with focus on structural and functional diversity, epidemiology and clinical significance.

Original languageEnglish
Pages (from-to)305-317
Number of pages13
JournalInternational journal of medical microbiology : IJMM
Volume303
Issue number6-7
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Microbial Drug Resistance
Kluyvera
Interspersed Repetitive Sequences
Replicon
Klebsiella pneumoniae
Enterobacteriaceae
Cephalosporins
Genes
Epidemiology
Clone Cells
Escherichia coli
Enzymes

Keywords

  • Antibiotic resistance
  • Clinical impact
  • CTX-M
  • Epidemiology
  • Extended-spectrum β-lactamases
  • Gram-negative pathogens

ASJC Scopus subject areas

  • Microbiology
  • Infectious Diseases
  • Microbiology (medical)

Cite this

CTX-M-type β-lactamases : A successful story of antibiotic resistance. / D'Andrea, Marco Maria; Arena, Fabio; Pallecchi, Lucia; Rossolini, Gian Maria.

In: International journal of medical microbiology : IJMM, Vol. 303, No. 6-7, 08.2013, p. 305-317.

Research output: Contribution to journalArticle

D'Andrea, Marco Maria ; Arena, Fabio ; Pallecchi, Lucia ; Rossolini, Gian Maria. / CTX-M-type β-lactamases : A successful story of antibiotic resistance. In: International journal of medical microbiology : IJMM. 2013 ; Vol. 303, No. 6-7. pp. 305-317.
@article{d3cfef3e74ba4b98b98e4be5faba71f5,
title = "CTX-M-type β-lactamases: A successful story of antibiotic resistance",
abstract = "Production of extended-spectrum β-lactamases (ESBLs) is the principal mechanism of resistance to oxyimino-cephalosporins evolved by members of the family Enterobacteriaceae. Among the several ESBLs emerged among clinical pathogens, the CTX-M-type enzymes have proved the most successful in terms of promiscuity and diffusion in different epidemiological settings, where they have largely replaced and outnumbered other types of ESBLs. Originated by the capture and mobilization of chromosomal β-lactamase genes of strains of Kluyvera species, the blaCTX-M genes have become associated with a variety of mobile genetic elements that have mediated rapid and efficient inter-replicon and cell-to-cell dissemination involving highly successful enterobacterial lineages (e.g. Escherichia coli ST131 and ST405, or Klebsiella pneumoniae CC11 and ST147) to yield high-risk multiresistant clones that have spread on a global scale. The CTX-Mβ-lactamase lineage exhibits a striking plasticity, with a large number of allelic variants belonging in several sublineages, which can be associated with functional heterogeneity of clinical relevance. This review article provides an update on CTX-M-type ESBLs, with focus on structural and functional diversity, epidemiology and clinical significance.",
keywords = "Antibiotic resistance, Clinical impact, CTX-M, Epidemiology, Extended-spectrum β-lactamases, Gram-negative pathogens",
author = "D'Andrea, {Marco Maria} and Fabio Arena and Lucia Pallecchi and Rossolini, {Gian Maria}",
year = "2013",
month = "8",
doi = "10.1016/j.ijmm.2013.02.008",
language = "English",
volume = "303",
pages = "305--317",
journal = "International Journal of Medical Microbiology",
issn = "1438-4221",
publisher = "Urban und Fischer Verlag GmbH und Co. KG",
number = "6-7",

}

TY - JOUR

T1 - CTX-M-type β-lactamases

T2 - A successful story of antibiotic resistance

AU - D'Andrea, Marco Maria

AU - Arena, Fabio

AU - Pallecchi, Lucia

AU - Rossolini, Gian Maria

PY - 2013/8

Y1 - 2013/8

N2 - Production of extended-spectrum β-lactamases (ESBLs) is the principal mechanism of resistance to oxyimino-cephalosporins evolved by members of the family Enterobacteriaceae. Among the several ESBLs emerged among clinical pathogens, the CTX-M-type enzymes have proved the most successful in terms of promiscuity and diffusion in different epidemiological settings, where they have largely replaced and outnumbered other types of ESBLs. Originated by the capture and mobilization of chromosomal β-lactamase genes of strains of Kluyvera species, the blaCTX-M genes have become associated with a variety of mobile genetic elements that have mediated rapid and efficient inter-replicon and cell-to-cell dissemination involving highly successful enterobacterial lineages (e.g. Escherichia coli ST131 and ST405, or Klebsiella pneumoniae CC11 and ST147) to yield high-risk multiresistant clones that have spread on a global scale. The CTX-Mβ-lactamase lineage exhibits a striking plasticity, with a large number of allelic variants belonging in several sublineages, which can be associated with functional heterogeneity of clinical relevance. This review article provides an update on CTX-M-type ESBLs, with focus on structural and functional diversity, epidemiology and clinical significance.

AB - Production of extended-spectrum β-lactamases (ESBLs) is the principal mechanism of resistance to oxyimino-cephalosporins evolved by members of the family Enterobacteriaceae. Among the several ESBLs emerged among clinical pathogens, the CTX-M-type enzymes have proved the most successful in terms of promiscuity and diffusion in different epidemiological settings, where they have largely replaced and outnumbered other types of ESBLs. Originated by the capture and mobilization of chromosomal β-lactamase genes of strains of Kluyvera species, the blaCTX-M genes have become associated with a variety of mobile genetic elements that have mediated rapid and efficient inter-replicon and cell-to-cell dissemination involving highly successful enterobacterial lineages (e.g. Escherichia coli ST131 and ST405, or Klebsiella pneumoniae CC11 and ST147) to yield high-risk multiresistant clones that have spread on a global scale. The CTX-Mβ-lactamase lineage exhibits a striking plasticity, with a large number of allelic variants belonging in several sublineages, which can be associated with functional heterogeneity of clinical relevance. This review article provides an update on CTX-M-type ESBLs, with focus on structural and functional diversity, epidemiology and clinical significance.

KW - Antibiotic resistance

KW - Clinical impact

KW - CTX-M

KW - Epidemiology

KW - Extended-spectrum β-lactamases

KW - Gram-negative pathogens

UR - http://www.scopus.com/inward/record.url?scp=84880753527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880753527&partnerID=8YFLogxK

U2 - 10.1016/j.ijmm.2013.02.008

DO - 10.1016/j.ijmm.2013.02.008

M3 - Article

C2 - 23490927

AN - SCOPUS:84880753527

VL - 303

SP - 305

EP - 317

JO - International Journal of Medical Microbiology

JF - International Journal of Medical Microbiology

SN - 1438-4221

IS - 6-7

ER -